Results for genitourinary translation from English to Maltese

genitourinary
Ġenitourinarju

gastrointestinal and genitourinary effects
effetti gastrointestinali u ġenitourinarji

recent gastrointestinal or genitourinary bleeding (within 10 days)
ħruġ tad-demm gastrointestinali jew ġenitourinarju reċenti (fl-aħħar 10 t’ijiem)

genitourinary bleeding (you may notice blood in your urine)
emorraġija ġenitourinarja (tista’ tinnota demm fl-awrina tiegħek)

recent gastrointestinal or genitourinary bleeding (within the past 10 days)
Ħruġ ta’ demm gastrointestinali jew ġenitourinarju riċenti (fl-aħħar 10 t’ijiem)

genitourinary skin/ soft tissue nasopharyngeal joint/ bone site unknown2 total
total

most frequently haemorrhage at the injection site, and occasionally genitourinary and gingival bleeding were observed.
emorraġija l-iktar frekwenti fis-sit ta’ l-injezzjoni, u kultant ħruġ ta’ demm ġenitourinarju u ġinġivali, kienu osservati l-aktar.

- common: as gastrointestinal (haematemesis, melena), gingival or genitourinary bleeding
- komuni: bħall- ħruġ tad- demm gastrointestinali (ematemesi, melena), ġenġivali jew

evidence of gastrointestinal bleeding, gross genitourinary bleeding or other active abnormal bleeding within the previous 30 days of treatment
evidenza ta’ fsada gastro-intestinali, fsada qawwija ġenitourinarja jew xi fsada oħra mhux normali attiva li seħħ matul it-30 jum ta’ qabel il-kura

cm gingival bleeding genitourinary gastrointestinal sheath puncture site retroperitoneal hemoptysis melena ear, nose or throat cardio/ pulmonary intracranial other
fsada ġinġivali Ġeniturinarja gastrointestinali sit ta ’ titqib tal- għant retroperitonali emoptissi melena widnejn, imnieħer jew

fatal events in patients treated with stivarga were uncommon (0.6%), and involved the respiratory, gastrointestinal and genitourinary tracts.
avvenimenti fatali f’pazjenti kkurati b’stivarga ma kienux komuni (0.6%), u kienu jinvolu l- apparati respiratorji, gastro-intestinali u ġenitourinarju.

in the clinical studies mucosal bleedings (e.g. epistaxis, gastrointestinal, genitourinary) and anaemia were seen more frequently during long term edoxaban treatment compared with vka treatment.
fl-istudji kliniċi fsad mill-mukuża (eż. jiġifieri epistassi, gastro-intestinali, mill-apparat ġenitali u tal- awrina) u anemija kienu osservati aktar ta’ spiss waqt kura fit-tul b’edoxaban meta mqabbla ma’ kura b’vka.

all potential bleeding sites, (e.g., catheter insertion sites; arterial, venous, or needle puncture sites; cutdown sites; gastrointestinal and genitourinary tracts) must be observed carefully.
il-partijiet kollha b’potenzjal ta’ fsada, (eż., partijiet minn fejn idda ħħal il-kateter; partijiet arterjali u tal-vini jew minn fejn daħlet il-labra; sit fejn issir inċiżjoni; l-apparat gastro-intestinali u dak ġenitourinarju) għandhom ikunu osservati b’attenzjoni.